@OrsoBio

Advancing first-in-class therapies to restore energy homeostasis

 Palo Alto, CA
orsobio.com
Joined October 2022
  • Tweets7
  • Following3
  • Followers60
A new biotech just dropped with a basket of assets, including two clinical-stage ones, from Gilead, Shionogi, Phenex Pharmaceuticals, Astellas’ Mitobridge and Yale. endpts.com/samsara-backs-ex-…

Updated: Samsara backs ex-Gilead duo's amalgamation of NASH, liver drug assets from former employ...

A new biotech just dropped with a basket of assets, including two clinical-stage ones, from Gilead, Shionogi, Phenex Pharmaceuticals, Astellas’ Mitobridge and Yale. The Palo Alto upstart is looking...

endpoints.news
2
3
OrsoBio launched Tuesday with Gilead alums Mani Subramanian, M.D., in the CEO seat and Rob Myers, M.D., serving as chief medical officer. fiercebiotech.com/biotech/5-…

5 press releases, one biotech: Gilead alums debut OrsoBio with frenzy of metabolic programs

OrsoBio is shouting its launch news from the rooftops. | Metabolic-disorder-focused OrsoBio launched Tuesday with Gilead alums Mani Subramanian, M.D., in the CEO seat and Rob Myers, M.D., serving as...

fiercebiotech.com
1
2
1
4
Load more